12:00 AM
 | 
Jan 14, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

VX15/2503: Phase I started

Vaccinex began a double-blind, placebo-controlled Phase I trial evaluating single ascending-doses of IV VX15/2503 in 50 patients with relapsing-remitting or secondary...

Read the full 84 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >